Nektar Therapeutics
NKTR
#4606
Rank
S$2.62 B
Marketcap
S$93.79
Share price
-2.50%
Change (1 day)
433.90%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$10.39

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$10.22. In 2024 the company made an earnings per share (EPS) of S-$11.36 an increase over its 2023 EPS that were of S-$28.07.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$10.39-8.55%
2024S-$11.36-59.54%
2023S-$28.07-25.89%
2022S-$37.87-31.12%
2021S-$54.9814.86%
2020S-$47.87-1.19%
2019S-$48.45-163.96%
2018S$75.75-725.4%
2017S-$12.11-42.73%
2016S-$21.1583.33%
2015S-$11.5439.53%
2014S-$8.27-69.29%
2013S-$26.92-6.67%
2012S-$28.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.27-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.74-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.37-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$0.85-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.36-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$6.86-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.08972-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.65-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland